ALIT
AlightCAI scenario view
RankAlpha Sentiment CodexThe current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
AI commentary
Recent headline coverage is thin. Stored third-party coverage described a negative initial Q2 share-price reaction despite results above its cited estimates, but that historical reaction is not the October 19 price move. Verified analyst revisions, options, short-interest, employee and sufficient social measurements are unavailable; zero fields denote missing data, not neutral readings.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Alight guided Q3 revenue to $469–$479 million and adjusted EBITDA to $55–$61 million, citing the effects of weak 2025 commercial execution and seasonally higher Q3 expenses. The date is an estimated reporting window, not an announced release date. [#SEC-8K-2026-08-04] https://www.sec.gov/Archives/edgar/data/1809104/000162828026052572/alit-20260630xexx991.htm
Alight disclosed lender discussions about a potential refinancing or extension, but said no satisfactory definitive agreement had been reached and it was not actively pursuing a transaction at that time. Resolution could materially affect the balance-sheet thesis; the date is a monitoring horizon, not a company deadline. The filing also warns against relying on older lender materials as current projections. [#8-K-2026-10-14] https://www.sec.gov/Archives/edgar/data/1809104/000162828026065893/alit-20261014.htm
Q2 revenue fell 3.2% year over year as lower net commercial activity outweighed higher project revenue. First-half operating cash flow was $152 million, while June 30 total debt was $1.996 billion. Sustained retention improvement and cash generation remain unproven; the date is an analytical horizon. [#SEC-8K-2026-08-04] https://www.sec.gov/Archives/edgar/data/1809104/000162828026052572/alit-20260630xexx991.htm
Recommendation
No formal recommendation provided.

